Gao J J, Song P P, Qi F H, Kokudo N, Qu X J, Tang W
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Drug Discov Ther. 2012 Feb;6(1):1-8.
Gastrointestinal cancer is a great threat to human health in Japan. Conventional anticancer therapies including surgery, radiation, and chemotherapy are the main strategies and play important roles in curing this disease or extending the life of patients with these cancers. On the other hand, patients undergo great suffering induced by these treatments. Kampo, the Japanese traditional medicine, has been used in clinics to reduce side effects and to improve the quality of life of gastrointestinal cancer patients in Japan. In order to testify to the efficacy and safety of these Kampo medicines and to clarify the underlying mechanisms, a number of clinical and basic studies were implemented in the past several decades. These studies suggested the benefits of Kampo medicine as an adjuvant to conventional anti-cancer therapies in treating gastrointestinal cancer. Since the safety and efficacy as well as quality control of traditional medicine have long been focused worldwide, the development course of Kampo medicine may provide reference to other countries in the world.
在日本,胃肠道癌症对人类健康构成巨大威胁。包括手术、放疗和化疗在内的传统抗癌疗法是主要治疗策略,在治愈这种疾病或延长这些癌症患者的生命方面发挥着重要作用。另一方面,患者会遭受这些治疗带来的巨大痛苦。日本传统医学汉方在日本的临床中已被用于减轻胃肠道癌症患者的副作用并提高其生活质量。为了证实这些汉方药物的疗效和安全性,并阐明其潜在机制,在过去几十年中开展了多项临床和基础研究。这些研究表明,汉方药物作为传统抗癌疗法的辅助手段在治疗胃肠道癌症方面具有益处。由于传统医学的安全性、有效性以及质量控制长期以来受到全球关注,汉方药物的发展历程可能为世界其他国家提供参考。